Combining HPV and MIB-1 tests reduces the number of colposcopies in women with equivocal cytology

References

• Cox JT. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Baillieres Clin Obstet Gynaecol 1995; 9(1)1–37
   PubMed Web of Science ®Google Scholar
• Guido R. Guidelines for screening and treatment of cervical disease in the adolescent. J Pediatr Adolesc Gynecol 2004; 17(5)303–11
   PubMedGoogle Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1)12–9
   PubMed Web of Science ®Google Scholar
• Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002; 3(1)11–6
   PubMed Web of Science ®Google Scholar
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338(7)423–8
   PubMed Web of Science ®Google Scholar
• Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87(18)1365–71
   PubMed Web of Science ®Google Scholar
• Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132(2)277–84
   PubMed Web of Science ®Google Scholar
• Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61(3)306–11
   PubMed Web of Science ®Google Scholar
• Kenemans P. HPV genotype as a prognostic factor for progression to cervical carcinoma in young women. Eur J Obstet Gynecol Reprod Biol 1994; 55(1)24–5
   PubMed Web of Science ®Google Scholar
• Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005; 99(3 Suppl 1)S7–11
   PubMed Web of Science ®Google Scholar
• Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993; 68(6)629–36
   PubMed Web of Science ®Google Scholar
• Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281(17)1605–10
   PubMed Web of Science ®Google Scholar
• Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93(4)293–9
   PubMedGoogle Scholar
• Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172(3)946–54
   PubMed Web of Science ®Google Scholar
• Hanselaar AG. Criteria for organized cervical screening programs. Special emphasis on The Netherlands program. Acta Cytol 2002; 46(4)619–29
   PubMed Web of Science ®Google Scholar
• Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283(1)87–93
   PubMed Web of Science ®Google Scholar
• Kok LP, Boon ME. Microwave Cookbook for Microscopists: Art and Science of Visualization, third revised edition. Coulomb Press, Leiden 1992; 266
   Google Scholar
• Boon ME, Vinkestein A, van Binsbergen-Ingelse A, van Haaften C. Significance of MiB-1 staining in smears with atypical glandular cells. Diagn Cytopathol 2004; 31(2)77–82
   PubMed Web of Science ®Google Scholar
• Boon ME, Kleinschmidt-Guy ED, Wijsman-Grootendorst A, Hoogeveen MM. Upgrading unsatisfactory cervical smears with the MiB-1 method. Diagn Cytopathol 1996; 15(4)270–6
   PubMed Web of Science ®Google Scholar
• Dunton CJ, van Hoeven KH, Kovatich AJ, Oliver RE, Scacheri RQ, Cater JR, et al. Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. Gynecol Oncol 1997; 64(3)451–5
   PubMed Web of Science ®Google Scholar
• Bekkers RLM. MIB1 and High-Risk HPV Detection as Markers for CIN3 in Cervical Scrapes. Clinical Value of High-Risk HPV Detection in the Management of Cervical Intraepithelial Neoplasia. Nijmegen: Ponsen & Looyen bv, 2003: 99–114.
   Google Scholar